Theralase Technologies Inc. (TLT) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.125x

Based on the latest financial reports, Theralase Technologies Inc. (TLT) has a cash flow conversion efficiency ratio of -0.125x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-244.54K ≈ $-176.90K USD) by net assets (CA$1.95 Million ≈ $1.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Theralase Technologies Inc. (TLT) defensive interval to measure how many days the company can operate on defensive assets alone.

Theralase Technologies Inc. - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Theralase Technologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Theralase Technologies Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theralase Technologies Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Opter AB ST:OPTER	0.230x
Suratwwala Business Group Limited NSE:SBGLP	0.004x
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares NASDAQ:ALCY	-1.295x
BCM Resources Corp V:B	-0.002x
NOMADAR Corp. Class A Common Stock NASDAQ:NOMA	-0.287x
Gold Hydrogen Ltd AU:GHY	-0.023x
Telcoware KO:078000	0.157x
Primotec Group Ltd TA:PRMG	0.071x

Annual Cash Flow Conversion Efficiency for Theralase Technologies Inc. (2001–2025)

The table below shows the annual cash flow conversion efficiency of Theralase Technologies Inc. from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see TLT market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$1.78 Million ≈ $1.29 Million	CA$-3.29 Million ≈ $-2.38 Million	-1.848x	-14.88%
2024-12-31	CA$2.07 Million ≈ $1.50 Million	CA$-3.33 Million ≈ $-2.41 Million	-1.609x	+24.73%
2023-12-31	CA$1.91 Million ≈ $1.38 Million	CA$-4.07 Million ≈ $-2.95 Million	-2.137x	-28.78%
2022-12-31	CA$3.09 Million ≈ $2.24 Million	CA$-5.13 Million ≈ $-3.71 Million	-1.660x	-108.79%
2021-12-31	CA$5.07 Million ≈ $3.67 Million	CA$-4.03 Million ≈ $-2.92 Million	-0.795x	-63.83%
2020-12-31	CA$9.16 Million ≈ $6.63 Million	CA$-4.45 Million ≈ $-3.22 Million	-0.485x	-2.38%
2019-12-31	CA$13.86 Million ≈ $10.02 Million	CA$-6.57 Million ≈ $-4.75 Million	-0.474x	+61.07%
2018-12-31	CA$998.64K ≈ $722.40K	CA$-1.22 Million ≈ $-879.39K	-1.217x	+41.54%
2017-12-31	CA$2.05 Million ≈ $1.48 Million	CA$-4.26 Million ≈ $-3.08 Million	-2.082x	-142.84%
2016-12-31	CA$5.69 Million ≈ $4.12 Million	CA$-4.88 Million ≈ $-3.53 Million	-0.858x	-7.39%
2015-12-31	CA$6.32 Million ≈ $4.57 Million	CA$-5.04 Million ≈ $-3.65 Million	-0.799x	+27.19%
2014-12-31	CA$3.31 Million ≈ $2.39 Million	CA$-3.63 Million ≈ $-2.62 Million	-1.097x	-111.05%
2013-12-31	CA$1.76 Million ≈ $1.28 Million	CA$-916.67K ≈ $-663.11K	-0.520x	-105.54%
2012-12-31	CA$-64.73K ≈ $-46.82K	CA$-606.72K ≈ $-438.89K	9.373x	+405.21%
2011-12-31	CA$455.16K ≈ $329.25K	CA$-1.40 Million ≈ $-1.01 Million	-3.071x	-663.82%
2010-12-31	CA$2.53 Million ≈ $1.83 Million	CA$-1.02 Million ≈ $-735.94K	-0.402x	-3323.44%
2009-12-31	CA$3.49 Million ≈ $2.52 Million	CA$-40.95K ≈ $-29.62K	-0.012x	+92.02%
2008-12-31	CA$2.39 Million ≈ $1.73 Million	CA$-351.19K ≈ $-254.05K	-0.147x	-41.17%
2007-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-351.49K ≈ $-254.26K	-0.104x	-1262.74%
2006-12-31	CA$3.37 Million ≈ $2.44 Million	CA$-25.78K ≈ $-18.65K	-0.008x	-130.39%
2005-12-31	CA$3.39 Million ≈ $2.45 Million	CA$85.33K ≈ $61.73K	0.025x	+130.40%
2004-12-31	CA$1.05 Million ≈ $762.12K	CA$-87.23K ≈ $-63.10K	-0.083x	+82.82%
2003-12-31	CA$399.21K ≈ $288.78K	CA$-192.39K ≈ $-139.17K	-0.482x	+13.24%
2002-12-31	CA$87.35K ≈ $63.19K	CA$-48.52K ≈ $-35.10K	-0.555x	+7.87%
2001-12-31	CA$137.03K ≈ $99.13K	CA$-82.62K ≈ $-59.76K	-0.603x	--

About Theralase Technologies Inc.

V:TLT Canada Medical Devices

Market Cap

$49.19 Million

CA$68.00 Million CAD

Market Cap Rank

#22007 Global

#780 in Canada

Share Price

CA$0.23

Change (1 day)

-4.17%

52-Week Range

CA$0.15 - CA$0.39

All Time High

CA$0.58